APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pseudovirus Neutralization Assay Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pseudovirus Neutralization Assay Service Market Outlook and Growth Opportunities 2026

1 January 2026190 pages

Choose your research edition.

Industry ResearchPseudovirus Neutralization Assay Service Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Pseudovirus Neutralization Assay Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pseudovirus Neutralization Assay Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pseudovirus Neutralization Assay Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pseudovirus Neutralization Assay Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pseudovirus Neutralization Assay Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pseudovirus Neutralization Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pseudovirus Neutralization Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pseudovirus Neutralization Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pseudovirus Neutralization Assay Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pseudovirus Neutralization Assay Service market include GenScript ProBio, ACROBiosystems, Creative-Diagnostics, eEnzyme, Abnova, Creative-Biogene, Creative Bioarray, Immuno Spot and Creative Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pseudovirus Neutralization Assay Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pseudovirus Neutralization Assay Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pseudovirus Neutralization Assay Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pseudovirus Neutralization Assay Service market.

Pseudovirus Neutralization Assay Service Segment by Company

GenScript ProBio

ACROBiosystems

Creative-Diagnostics

eEnzyme

Abnova

Creative-Biogene

Creative Bioarray

Immuno Spot

Creative Diagnostics

Cellecta

RayBiotech

ACROBiosystems Group

Pseudovirus Neutralization Assay Service Segment by Type

Specific NAb Assay

Anti-SARS-CoV-2 NAb Assay

Pseudovirus Neutralization Assay Service Segment by Application

Hospital

Research Institute

Others

Pseudovirus Neutralization Assay Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pseudovirus Neutralization Assay Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pseudovirus Neutralization Assay Service key companies, revenue, market share, and recent developments.

3. To split the Pseudovirus Neutralization Assay Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pseudovirus Neutralization Assay Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pseudovirus Neutralization Assay Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pseudovirus Neutralization Assay Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pseudovirus Neutralization Assay Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pseudovirus Neutralization Assay Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pseudovirus Neutralization Assay Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pseudovirus Neutralization Assay Service industry.

Chapter 3: Detailed analysis of Pseudovirus Neutralization Assay Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pseudovirus Neutralization Assay Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pseudovirus Neutralization Assay Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pseudovirus Neutralization Assay Service Industry Trends Table 2. Pseudovirus Neutralization Assay Service Industry Drivers Table 3. Pseudovirus Neutralization Assay Service Industry Opportunities and Challenges Table 4. Pseudovirus Neutralization Assay Service Industry Restraints Table 5. Global Pseudovirus Neutralization Assay Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pseudovirus Neutralization Assay Service Revenue Share by Company (2021-2026) Table 7. Global Pseudovirus Neutralization Assay Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pseudovirus Neutralization Assay Service Key Company Manufacturing Base & Headquarters Table 9. Global Pseudovirus Neutralization Assay Service Company, Product Type & Application Table 10. Global Pseudovirus Neutralization Assay Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pseudovirus Neutralization Assay Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Specific NAb Assay Table 15. Significant Companies of Anti-SARS-CoV-2 NAb Assay Table 16. Global Pseudovirus Neutralization Assay Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pseudovirus Neutralization Assay Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pseudovirus Neutralization Assay Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pseudovirus Neutralization Assay Service Sales Value Share by Type (2021-2026) Table 20. Global Pseudovirus Neutralization Assay Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Research Institute Table 23. Significant Companies of Others Table 24. Global Pseudovirus Neutralization Assay Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pseudovirus Neutralization Assay Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pseudovirus Neutralization Assay Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pseudovirus Neutralization Assay Service Sales Value Share by Application (2021-2026) Table 28. Global Pseudovirus Neutralization Assay Service Sales Value Share by Application (2027-2032) Table 29. Global Pseudovirus Neutralization Assay Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pseudovirus Neutralization Assay Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pseudovirus Neutralization Assay Service Sales Value Share by Region (2021-2026) Table 32. Global Pseudovirus Neutralization Assay Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pseudovirus Neutralization Assay Service Sales Value Share by Region (2027-2032) Table 34. Global Pseudovirus Neutralization Assay Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pseudovirus Neutralization Assay Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pseudovirus Neutralization Assay Service Sales Value Market Share by Country (2021-2026) Table 37. Global Pseudovirus Neutralization Assay Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pseudovirus Neutralization Assay Service Sales Value Market Share by Country (2027-2032) Table 39. GenScript ProBio Company Information Table 40. GenScript ProBio Business Overview Table 41. GenScript ProBio Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. GenScript ProBio Pseudovirus Neutralization Assay Service Product Portfolio Table 43. GenScript ProBio Recent Development Table 44. ACROBiosystems Company Information Table 45. ACROBiosystems Business Overview Table 46. ACROBiosystems Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. ACROBiosystems Pseudovirus Neutralization Assay Service Product Portfolio Table 48. ACROBiosystems Recent Development Table 49. Creative-Diagnostics Company Information Table 50. Creative-Diagnostics Business Overview Table 51. Creative-Diagnostics Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Creative-Diagnostics Pseudovirus Neutralization Assay Service Product Portfolio Table 53. Creative-Diagnostics Recent Development Table 54. eEnzyme Company Information Table 55. eEnzyme Business Overview Table 56. eEnzyme Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. eEnzyme Pseudovirus Neutralization Assay Service Product Portfolio Table 58. eEnzyme Recent Development Table 59. Abnova Company Information Table 60. Abnova Business Overview Table 61. Abnova Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Abnova Pseudovirus Neutralization Assay Service Product Portfolio Table 63. Abnova Recent Development Table 64. Creative-Biogene Company Information Table 65. Creative-Biogene Business Overview Table 66. Creative-Biogene Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Creative-Biogene Pseudovirus Neutralization Assay Service Product Portfolio Table 68. Creative-Biogene Recent Development Table 69. Creative Bioarray Company Information Table 70. Creative Bioarray Business Overview Table 71. Creative Bioarray Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Creative Bioarray Pseudovirus Neutralization Assay Service Product Portfolio Table 73. Creative Bioarray Recent Development Table 74. Immuno Spot Company Information Table 75. Immuno Spot Business Overview Table 76. Immuno Spot Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Immuno Spot Pseudovirus Neutralization Assay Service Product Portfolio Table 78. Immuno Spot Recent Development Table 79. Creative Diagnostics Company Information Table 80. Creative Diagnostics Business Overview Table 81. Creative Diagnostics Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Creative Diagnostics Pseudovirus Neutralization Assay Service Product Portfolio Table 83. Creative Diagnostics Recent Development Table 84. Cellecta Company Information Table 85. Cellecta Business Overview Table 86. Cellecta Pseudovirus Neutralization Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Cellecta Pseudovirus Neutralization Assay Service Product Portfolio Table 88. Cellecta Recent Development Table 89. RayBiotech Company Information Table 90. RayBiotech Business Overview Table 91. RayBiotech Pseudovirus Neutralization Assay Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. RayBiotech Pseudovirus Neutralization Assay Service Product Portfolio Table 93. RayBiotech Recent Development Table 94. ACROBiosystems Group Company Information Table 95. ACROBiosystems Group Business Overview Table 96. ACROBiosystems Group Pseudovirus Neutralization Assay Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. ACROBiosystems Group Pseudovirus Neutralization Assay Service Product Portfolio Table 98. ACROBiosystems Group Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Pseudovirus Neutralization Assay Service Product Image Figure 2. Global Pseudovirus Neutralization Assay Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pseudovirus Neutralization Assay Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pseudovirus Neutralization Assay Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Specific NAb Assay Image Figure 8. Anti-SARS-CoV-2 NAb Assay Image Figure 9. Global Pseudovirus Neutralization Assay Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pseudovirus Neutralization Assay Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pseudovirus Neutralization Assay Service Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Research Institute Image Figure 14. Others Image Figure 15. Global Pseudovirus Neutralization Assay Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pseudovirus Neutralization Assay Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pseudovirus Neutralization Assay Service Sales Value Share by Application (2021-2032) Figure 18. Global Pseudovirus Neutralization Assay Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pseudovirus Neutralization Assay Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pseudovirus Neutralization Assay Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pseudovirus Neutralization Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pseudovirus Neutralization Assay Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pseudovirus Neutralization Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pseudovirus Neutralization Assay Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pseudovirus Neutralization Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pseudovirus Neutralization Assay Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pseudovirus Neutralization Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pseudovirus Neutralization Assay Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pseudovirus Neutralization Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Specific NAb Assay
  • Anti-SARS-CoV-2 NAb Assay
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • GenScript ProBio
  • ACROBiosystems
  • Creative-Diagnostics
  • eEnzyme
  • Abnova
  • Creative-Biogene
  • Creative Bioarray
  • Immuno Spot
  • Creative Diagnostics
  • Cellecta
  • RayBiotech
  • ACROBiosystems Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pseudovirus Neutralization Assay Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pseudovirus Neutralization Assay Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pseudovirus Neutralization Assay Service Market Dynamics
  1. 2.1 Pseudovirus Neutralization Assay Service Industry Trends
  2. 2.2 Pseudovirus Neutralization Assay Service Industry Drivers
  3. 2.3 Pseudovirus Neutralization Assay Service Industry Opportunities and Challenges
  4. 2.4 Pseudovirus Neutralization Assay Service Industry Restraints
3 Pseudovirus Neutralization Assay Service Market by Company
  1. 3.1 Global Pseudovirus Neutralization Assay Service Company Revenue Ranking in 2025
  2. 3.2 Global Pseudovirus Neutralization Assay Service Revenue by Company (2021-2026)
  3. 3.3 Global Pseudovirus Neutralization Assay Service Company Ranking (2024-2026)
  4. 3.4 Global Pseudovirus Neutralization Assay Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pseudovirus Neutralization Assay Service Company Product Type and Application
  6. 3.6 Global Pseudovirus Neutralization Assay Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pseudovirus Neutralization Assay Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pseudovirus Neutralization Assay Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pseudovirus Neutralization Assay Service Market by Type
  1. 4.1 Pseudovirus Neutralization Assay Service Type Introduction
  2. 4.1.1 Specific NAb Assay
  3. 4.1.2 Anti-SARS-CoV-2 NAb Assay
  4. 4.2 Global Pseudovirus Neutralization Assay Service Sales Value by Type
  5. 4.2.1 Global Pseudovirus Neutralization Assay Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pseudovirus Neutralization Assay Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pseudovirus Neutralization Assay Service Sales Value Share by Type (2021-2032)
5 Pseudovirus Neutralization Assay Service Market by Application
  1. 5.1 Pseudovirus Neutralization Assay Service Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Pseudovirus Neutralization Assay Service Sales Value by Application
  6. 5.2.1 Global Pseudovirus Neutralization Assay Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pseudovirus Neutralization Assay Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pseudovirus Neutralization Assay Service Sales Value Share by Application (2021-2032)
6 Pseudovirus Neutralization Assay Service Regional Value Analysis
  1. 6.1 Global Pseudovirus Neutralization Assay Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pseudovirus Neutralization Assay Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pseudovirus Neutralization Assay Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pseudovirus Neutralization Assay Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pseudovirus Neutralization Assay Service Sales Value (2021-2032)
  7. 6.3.2 North America Pseudovirus Neutralization Assay Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pseudovirus Neutralization Assay Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pseudovirus Neutralization Assay Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pseudovirus Neutralization Assay Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pseudovirus Neutralization Assay Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pseudovirus Neutralization Assay Service Sales Value (2021-2032)
  16. 6.6.2 South America Pseudovirus Neutralization Assay Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pseudovirus Neutralization Assay Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pseudovirus Neutralization Assay Service Sales Value Share by Country, 2025 VS 2032
7 Pseudovirus Neutralization Assay Service Country-level Value Analysis
  1. 7.1 Global Pseudovirus Neutralization Assay Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pseudovirus Neutralization Assay Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pseudovirus Neutralization Assay Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pseudovirus Neutralization Assay Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pseudovirus Neutralization Assay Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pseudovirus Neutralization Assay Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pseudovirus Neutralization Assay Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GenScript ProBio
  2. 8.1.1 GenScript ProBio Company Information
  3. 8.1.2 GenScript ProBio Business Overview
  4. 8.1.3 GenScript ProBio Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GenScript ProBio Pseudovirus Neutralization Assay Service Product Portfolio
  6. 8.1.5 GenScript ProBio Recent Developments
  7. 8.2 ACROBiosystems
  8. 8.2.1 ACROBiosystems Company Information
  9. 8.2.2 ACROBiosystems Business Overview
  10. 8.2.3 ACROBiosystems Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ACROBiosystems Pseudovirus Neutralization Assay Service Product Portfolio
  12. 8.2.5 ACROBiosystems Recent Developments
  13. 8.3 Creative-Diagnostics
  14. 8.3.1 Creative-Diagnostics Company Information
  15. 8.3.2 Creative-Diagnostics Business Overview
  16. 8.3.3 Creative-Diagnostics Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Creative-Diagnostics Pseudovirus Neutralization Assay Service Product Portfolio
  18. 8.3.5 Creative-Diagnostics Recent Developments
  19. 8.4 eEnzyme
  20. 8.4.1 eEnzyme Company Information
  21. 8.4.2 eEnzyme Business Overview
  22. 8.4.3 eEnzyme Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 eEnzyme Pseudovirus Neutralization Assay Service Product Portfolio
  24. 8.4.5 eEnzyme Recent Developments
  25. 8.5 Abnova
  26. 8.5.1 Abnova Company Information
  27. 8.5.2 Abnova Business Overview
  28. 8.5.3 Abnova Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Abnova Pseudovirus Neutralization Assay Service Product Portfolio
  30. 8.5.5 Abnova Recent Developments
  31. 8.6 Creative-Biogene
  32. 8.6.1 Creative-Biogene Company Information
  33. 8.6.2 Creative-Biogene Business Overview
  34. 8.6.3 Creative-Biogene Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Creative-Biogene Pseudovirus Neutralization Assay Service Product Portfolio
  36. 8.6.5 Creative-Biogene Recent Developments
  37. 8.7 Creative Bioarray
  38. 8.7.1 Creative Bioarray Company Information
  39. 8.7.2 Creative Bioarray Business Overview
  40. 8.7.3 Creative Bioarray Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Creative Bioarray Pseudovirus Neutralization Assay Service Product Portfolio
  42. 8.7.5 Creative Bioarray Recent Developments
  43. 8.8 Immuno Spot
  44. 8.8.1 Immuno Spot Company Information
  45. 8.8.2 Immuno Spot Business Overview
  46. 8.8.3 Immuno Spot Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Immuno Spot Pseudovirus Neutralization Assay Service Product Portfolio
  48. 8.8.5 Immuno Spot Recent Developments
  49. 8.9 Creative Diagnostics
  50. 8.9.1 Creative Diagnostics Company Information
  51. 8.9.2 Creative Diagnostics Business Overview
  52. 8.9.3 Creative Diagnostics Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Creative Diagnostics Pseudovirus Neutralization Assay Service Product Portfolio
  54. 8.9.5 Creative Diagnostics Recent Developments
  55. 8.10 Cellecta
  56. 8.10.1 Cellecta Company Information
  57. 8.10.2 Cellecta Business Overview
  58. 8.10.3 Cellecta Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cellecta Pseudovirus Neutralization Assay Service Product Portfolio
  60. 8.10.5 Cellecta Recent Developments
  61. 8.11 RayBiotech
  62. 8.11.1 RayBiotech Company Information
  63. 8.11.2 RayBiotech Business Overview
  64. 8.11.3 RayBiotech Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 RayBiotech Pseudovirus Neutralization Assay Service Product Portfolio
  66. 8.11.5 RayBiotech Recent Developments
  67. 8.12 ACROBiosystems Group
  68. 8.12.1 ACROBiosystems Group Company Information
  69. 8.12.2 ACROBiosystems Group Business Overview
  70. 8.12.3 ACROBiosystems Group Pseudovirus Neutralization Assay Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ACROBiosystems Group Pseudovirus Neutralization Assay Service Product Portfolio
  72. 8.12.5 ACROBiosystems Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst